Research progress of bortezomib-induced peripheral neuropathy
Hengfei Du
Abstract
Hengfei Du
Abstract
Proteasome inhibitor bortezomib has been used to treat various of tumors,its most important side effect is peripheral neuropathy,which limits its clinical application.This paper briefly described the etiology and risk factors of bortezomib-induced peripheral neuropathy (BIPN),the pathological mechanism,the clinical manifestation,the method of detection and evaluation.And the prevention and treatment of BIPN are introduced. Key words: Bortezomib; Multiple myeloma; Peripheral neuropathy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Proteasome inhibitor bortezomib has been used to treat various of tumors,its most important side effect is peripheral neuropathy,which limits its clinical application.This paper briefly described the etiology and risk factors of bortezomib-induced peripheral neuropathy (BIPN),the pathological mechanism,the clinical manifestation,the method of detection and evaluation.And the prevention and treatment of BIPN are introduced. Key words: Bortezomib; Multiple myeloma; Peripheral neuropathy
Key concepts: Bortezomib, Peripheral neuropathy, Medicine, Multiple myeloma, Proteasome inhibitor, Pathological, Etiology, Oncology